RT Conference Proceedings
T1 SOLTI-1507: A phase Ib study of ipatasertib and anti-HER2 therapy in HER2-positive advanced breast cancer with PIK3CA mutation (IPATHER)
A1 Oliveira, M.
A1 Villagrasa, P.
A1 Ciruelos, E. M.
A1 Gavila, J.
A1 Cortegoso, A.
A1 Henao, F.
A1 Vega, E.
A1 Salvador, J.
A1 Quiroga, V.
A1 Estevez, L. G.
A1 Morales, S.
A1 Tolosa, P.
A1 Salvador, F.
A1 Gonzalez, X.
A1 Saura, C.
PB Elsevier
SN 0923-7534
YR 2020
FD 2020-09-01
LK https://hdl.handle.net/10668/27556
UL https://hdl.handle.net/10668/27556
LA en
DS RISalud
RD Apr 5, 2025